Showing results (71-80 of 187) with videos related to

Sort By:
Pageof 19
Oncotarget|September 1, 2016
Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancerLi-Ching Fan, Hao-Wei Teng, Chung-Wai Shiau, et al.
Springerplus|August 27, 2016
Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?Yi-Jian Tsai, Jen-Kou Lin, Wei-Shone Chen, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal CancerLi-Ching Fan, Hao-Wei Teng, Chung-Wai Shiau, et al.
The Journal of Biological Chemistry|July 26, 2015
Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce AngiogenesisAi-Chung Mar, Chun-Ho Chu, Hui-Ju Lee, et al.
World Journal of Surgical Oncology|March 16, 2016
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case reportHung-Hsin Lin, Chia-Chu Chang, Shung-Haur Yang, et al.
Diseases of the Colon and Rectum|March 29, 2005
Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosisHuann-Sheng Wang, Wen-Yih Liang, Tzu-Chen Lin, et al.
Hepato-Gastroenterology|October 26, 2011
Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normalYuan-Tzu Lan, Jen-Kou Lin, Tzu-Chen Lin, et al.
American Journal of Clinical Oncology|October 22, 2014
Reduced-intensity FOLFOXIRI in Treating Refractory Metastatic Colorectal Cancer: A Pilot StudyHung-Ming Chen, Jen-Kou Lin, Wei-Shone Chen, et al.
Oncology Letters|October 17, 2024
MicroRNA‑24 alleviates colorectal cancer progression via a rs28382740 single nucleotide polymorphism in the long noncoding region of X‑linked inhibitor of apoptosis proteinYu-Feng Tian, Chi-Jung Huang, Chih-Yi Liu, et al.
The International Journal of Biological Markers|April 6, 2013
Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidencePei-Ching Lin, Hung-Hsin Lin, Jen-Kou Lin, et al.
Pageof 19